In our study published in Nature Medicine (Koukouli et al. 2017), we showed that human mutations of nicotinic receptors associated with psychiatric disorders modulate hypofrontality through a hierarchical circuit of inhibitory neurons and chronic nicotine administration reverses this hypofrontality. This finding paves the way to new therapeutic strategies targeting nicotinic receptors in mental disorders.
Press release: https://www.pasteur.fr/en/how-nicotine-acts-brains-schizophrenic-patients
Nature Medicine News and Views: http://www.nature.com/nm/journal/v23/n3/full/nm.4300.html
